1. Home
  2. AMBA vs HCM Comparison

AMBA vs HCM Comparison

Compare AMBA & HCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ambarella Inc.

AMBA

Ambarella Inc.

HOLD

Current Price

$50.42

Market Cap

2.3B

Sector

Technology

ML Signal

HOLD

Logo HUTCHMED (China) Limited

HCM

HUTCHMED (China) Limited

HOLD

Current Price

$13.93

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMBA
HCM
Founded
2004
2000
Country
United States
Hong Kong
Employees
N/A
1811
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.4B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
AMBA
HCM
Price
$50.42
$13.93
Analyst Decision
Strong Buy
Sell
Analyst Count
9
1
Target Price
$97.25
$13.75
AVG Volume (30 Days)
911.2K
20.7K
Earning Date
02-26-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
37.32
N/A
EPS
N/A
N/A
Revenue
$295,402,000.00
N/A
Revenue This Year
$15.69
$28.37
Revenue Next Year
$13.06
$17.50
P/E Ratio
N/A
$5.49
Revenue Growth
N/A
N/A
52 Week Low
$38.90
$11.51
52 Week High
$96.69
$19.50

Technical Indicators

Market Signals
Indicator
AMBA
HCM
Relative Strength Index (RSI) 31.98 44.22
Support Level N/A $13.92
Resistance Level $71.00 $14.80
Average True Range (ATR) 2.15 0.35
MACD 0.17 0.03
Stochastic Oscillator 7.16 20.77

Price Performance

Historical Comparison
AMBA
HCM

About AMBA Ambarella Inc.

Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, security cameras, consumer cameras, and industrial and robotic applications. The company's system-on-a-chip designs, based on its proprietary technology platform, are configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

Share on Social Networks: